Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma
Our study showed that both the MIP/SOL pattern and molecular high-risk category were adverse prognostic factors in stage IB NSCLC patients. Our results suggest that combining histologic classification and molecular risk stratification may help to identify the subset of patients with poor prognosis.
Authors
- Dongsheng Yue
- Zhenfa Zhang (ORCID: https://orcid.org/0000-0002-9627-2590)
- Hirokazu Iso (ORCID: https://orcid.org/0000-0002-3672-679X)
- Kakeru Hisakane (ORCID: https://orcid.org/0000-0002-9108-2050)
- Songan Chen
- Jiping Xie (ORCID: https://orcid.org/0000-0002-8602-2774)
- Haiwei Du (ORCID: https://orcid.org/0000-0002-4329-2088)
- Qiang Zhang (ORCID: https://orcid.org/0000-0002-2707-0258)
- Bin Zhang (ORCID: https://orcid.org/0000-0001-8835-8370)
- Chen Chen (ORCID: https://orcid.org/0000-0002-7957-0289)
- Weiran Liu (ORCID: https://orcid.org/0000-0002-5457-3563)
- Xinyi Wu (ORCID: https://orcid.org/0009-0004-4437-7157)
- Lin Shao
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Burning Rock Biotech (China) (CN)
- Nippon Medical School (JP)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/tlcr-24-506
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China